| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ... New England Journal of Medicine 369 (14), 1317-1326, 2013 | 4208 | 2013 |
| Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial BM Scirica, E Braunwald, I Raz, MA Cavender, DA Morrow, P Jarolim, ... Circulation 130 (18), 1579-1588, 2014 | 869 | 2014 |
| Sotagliflozin in patients with diabetes and chronic kidney disease DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ... New England Journal of Medicine 384 (2), 129-139, 2021 | 856 | 2021 |
| Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JA Udell, R Zawi, DL Bhatt, M Keshtkar-Jahromi, F Gaughran, ... Jama 310 (16), 1711-1720, 2013 | 588 | 2013 |
| Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials Y Lytvyn, P Bjornstad, JA Udell, JA Lovshin, DZI Cherney Circulation 136 (17), 1643-1658, 2017 | 486 | 2017 |
| Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta … JA Udell, MP Bonaca, JP Collet, AM Lincoff, DJ Kereiakes, F Costa, ... European heart journal 37 (4), 390-399, 2016 | 447 | 2016 |
| Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials JA Udell, MA Cavender, DL Bhatt, S Chatterjee, ME Farkouh, BM Scirica The lancet Diabetes & endocrinology 3 (5), 356-366, 2015 | 291 | 2015 |
| Does this patient with liver disease have cirrhosis? JA Udell, CS Wang, J Tinmouth, JM FitzGerald, NT Ayas, DL Simel, ... Jama 307 (8), 832-842, 2012 | 259 | 2012 |
| A multicenter observational study of incretin-based drugs and heart failure KB Filion, L Azoulay, RW Platt, M Dahl, CR Dormuth, KK Clemens, N Hu, ... New England Journal of Medicine 374 (12), 1145-1154, 2016 | 246 | 2016 |
| Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for … JA Udell, Z Yuan, T Rush, NM Sicignano, M Galitz, N Rosenthal Circulation 137 (14), 1450-1459, 2018 | 232 | 2018 |
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial JA Udell, DL Bhatt, E Braunwald, MA Cavender, O Mosenzon, PG Steg, ... Diabetes care 38 (4), 696-705, 2015 | 216 | 2015 |
| Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study BM Hicks, KB Filion, H Yin, L Sakr, JA Udell, L Azoulay bmj 363, 2018 | 210 | 2018 |
| 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy SR Mehta, KR Bainey, WJ Cantor, M Lordkipanidzé, G Marquis-Gravel, ... Canadian Journal of Cardiology 34 (3), 214-233, 2018 | 199 | 2018 |
| Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial O Vardeny, B Claggett, JA Udell, M Packer, M Zile, J Rouleau, ... JACC: Heart Failure 4 (2), 152-158, 2016 | 170 | 2016 |
| The Cardiovascular Health in Ambulatory Care Research Team (CANHEART) using big data to measure and improve cardiovascular health and healthcare services JV Tu, A Chu, LR Donovan, DT Ko, GL Booth, K Tu, LC Maclagan, H Guo, ... Circulation: Cardiovascular Quality and Outcomes 8 (2), 204-212, 2015 | 170 | 2015 |
| Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis JA Udell, PG Steg, BM Scirica, SC Smith, EM Ohman, KA Eagle, S Goto, ... Archives of internal medicine 172 (14), 1086-1095, 2012 | 167 | 2012 |
| The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ... American Heart Journal 162 (5), 818-825. e6, 2011 | 135 | 2011 |
| Association of influenza-like illness activity with hospitalizations for heart failure: the atherosclerosis risk in communities study S Kytömaa, S Hegde, B Claggett, JA Udell, W Rosamond, J Temte, ... JAMA cardiology 4 (4), 363-369, 2019 | 130 | 2019 |
| Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and … OR Ghosh-Swaby, SG Goodman, LA Leiter, A Cheng, KA Connelly, ... The lancet Diabetes & endocrinology 8 (5), 418-435, 2020 | 121 | 2020 |
| Heart failure outcomes in clinical trials of glucose‐lowering agents in patients with diabetes DH Fitchett, JA Udell, SE Inzucchi European journal of heart failure 19 (1), 43-53, 2017 | 118 | 2017 |
Deepak L. Bhatt, MD, MPH, MBADr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount SinaiVerified email at post.harvard.edu
